Autism Spectrum Disorder (ASD): Diagnostic Domains, Neurobiology, Co-Occurring Conditions and Support Frameworks
A neurodevelopmental and clinical reference on the two DSM-5-TR diagnostic domains, functional support levels, genetic and neurobiological findings, common co-occurring conditions, and evidence-based support principles.
Submitted research brief - Submitted to OwieClear; written with an AI assistant - November 2026
Read this first. This document was written outside OwieClear and has not been reviewed by a clinician. We publish it so you can read the source for yourself. It is educational and is not medical advice. Where our own pages disagree with it, follow our pages, which cite their sources, and ask a healthcare professional about anything that affects your care.
What we found that needs correcting
- This brief is accurate, respectful in tone, and better calibrated than most writing on autism. The notes below are omissions and points of emphasis rather than errors.
- Applied behaviour analysis is not mentioned at all, and that is the largest gap. ABA is the most widely funded autism intervention in the United States, it has the largest outcome literature of any approach, and it is strongly contested by many autistic adults who describe goals aimed at appearing non-autistic, suppression of stimming and enforced eye contact. A reader deciding about services cannot avoid this question, and a brief on intervention principles should help them ask it: what are the goals, who chose them, how many hours, is stimming targeted, and is the aim skills and autonomy or appearing typical.
- There is nothing on unproven and harmful treatments, and this is a safety gap. Chelation has killed children. Chlorine dioxide, sold as miracle mineral solution, is industrial bleach and is marketed for autism despite repeated FDA warnings. Hyperbaric oxygen, unregulated stem cell clinics and faecal transplants outside trials are all sold to families. Restrictive gluten-free and casein-free diets have been tested without benefit and carry nutritional risk in children who already eat selectively. In a field with this much predatory marketing, naming these is as important as naming what works.
- The neurobiology section states early brain overgrowth and the local hyper-connectivity with reduced long-range synchronization model more confidently than the evidence supports. Both findings come from group studies with substantial overlap between autistic and non-autistic people, replication has been inconsistent, and connectivity findings vary with age, task and method. The brief should say plainly that none of these is diagnostic and that no scan, blood test or biomarker identifies autism in an individual.
- The epilepsy figure of 15 to 25 percent is accurate for autistic people overall and conceals an important distinction: the association is driven largely by co-occurring intellectual disability. In autistic people without intellectual disability, rates are considerably lower and closer to the general population.
- Diagnostic overshadowing is not named, and it is the mechanism through which most of the co-occurring conditions in section 4 go untreated. Once someone has an autism diagnosis, new symptoms get attributed to it rather than investigated. It contributes materially to the shorter average life expectancy documented in autistic people, much of which comes from treatable conditions.
- Screening is not covered. Routine developmental screening at 18 and 24 months, usually with the M-CHAT, is standard practice in the United States, and a positive screen indicates the need for full assessment rather than being a diagnosis. The brief also does not say that early intervention can and should begin on identified needs without waiting for a formal diagnosis, which matters given how long waiting lists are.
- Autistic catatonia is not mentioned. It can appear in adolescence or young adulthood as deterioration in movement, speech and initiation, is frequently mistaken for regression or worsening autism, and is treatable. Its omission from a co-occurring conditions section is notable.
- Risperidone and aripiprazole are correctly described as reserved for severe irritability and self-injury. The side effects should be stated: weight gain, metabolic changes, sedation and raised prolactin are common and require monitoring. The brief says they are reserved without saying why.
- Mental health risk is described in terms of anxiety, depression and burnout. Autistic people are also at substantially higher risk of self-harm and suicide than the general population, which is a reason for proactive, adapted mental health care, and a brief that lists mental health co-occurrences should say so.
- The support levels section is well written and could add one caution: the levels are routinely misread as severity grades or fixed labels, and are frequently collapsed into a single number despite being assigned separately for each domain. The brief notes they can fluctuate, which is the right instinct.
- On terminology: the brief uses respectful language throughout. It could note that most autistic people and self-advocacy organizations prefer identity-first language, autistic person, and that high-functioning and low-functioning are not clinical terms and are widely rejected.
- A historical note on Asperger's syndrome: beyond being folded into ASD in DSM-5, historical research published in 2018 documented Hans Asperger's cooperation with the Nazi child euthanasia programme, which is a further reason the eponym has been retired.
- Everything else in the brief is accurate: the two-domain structure with its three social communication and four restricted and repetitive components; sensory differences included in Domain B; onset in the developmental period with the caveat that traits may not manifest until demands exceed masking capacity; the consolidation of previously separate diagnoses in DSM-5-TR and ICD-11; heritability of 70 to 90 percent with polygenic architecture and 10 to 20 percent rare de novo variants; the named genes and their convergence on chromatin remodelling, neuronal migration and synaptic scaffolding; advanced parental age, extreme prematurity and valproate as modest prenatal modifiers; the clear statement that vaccines do not cause autism; ADHD, intellectual disability and language and coordination disorders as co-occurrences; masking and its link to exhaustion and burnout, particularly in women and late-diagnosed adults; and the intervention principles, AAC offered early, naturalistic developmental behavioural interventions, sensory accommodation, environmental modification rather than enforced conformity, and medication only for co-occurring conditions.
Download the PDF
Our reviewed pages on this
All source documents